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Abstract
The potential role and function of gastrokine-1 (GNK1) in smooth muscle cells is investigated in this work by first
establishing a preparative protocol to obtain this native protein from freshly dissected chicken gizzard. Some unexpected
biochemical properties of gastrokine-1 were deduced by producing specific polyclonal antibody against the purified
protein. We focused on the F-actin interaction with gastrokine-1 and the potential role and function in smooth muscle
contractile properties.
Background: GNK1 is thought to provide mucosal protection in the superficial gastric epithelium. However, the actual role
of gastrokine-1 with regards to its known decreased expression in gastric cancer is still unknown. Recently, trefoil factors
(TFF) were reported to have important roles in gastric epithelial regeneration and cell turnover, and could be involved in
GNK1 interactions. The aim of this study was to evaluate the role and function of GNK1 in smooth muscle cells.
Methodology/Principal Findings: From fresh chicken gizzard smooth muscle, an original purification procedure was used
to purify a heat soluble 20 kDa protein that was sequenced and found to correspond to the gastrokine-1 protein sequence
containing one BRICHOS domain and at least two or possibly three transmembrane regions. The purified protein was used
to produce polyclonal antibody and highlighted the smooth muscle cell distribution and F-actin association of GNK1
through a few different methods.
Conclusion/Significance: Altogether our data illustrate a broader distribution of gastrokine-1 in smooth muscle than only in
the gastrointestinal epithelium, and the specific interaction with F-actin highlights and suggests a new role and function of
GNK1 within smooth muscle cells. A potential role via TFF interaction in cell-cell adhesion and assembly of actin stress fibres
is discussed.
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Introduction
Gastrokine-1 is a rather novel protein that is highly expressed in
normal stomach and located in the superficial gastric epithelium.
Gastrokine-1 is abundantly and specifically expressed in superficial
gastric epithelium [1] but its function is not yet known. The current
postulated role of gastrokine-1 in mucosal protection was deduced
from its cellular localisation in the gastric epithelium. In previous
reports, gastrokine-1 (GKN1), named before AMP-18 [2,3] or
CA11 [4,5], was already known to be highly expressed in gastric
antrum mucosa cells [6,7,8]. Previously generated mRNA expres-
sion profiles of gastric carcinoma were compared with those of
normal gastric antrum and led to the identification of the
gastrokine-1 transcript, which accounted for around 1% of the
total mRNA in normal stomach but was absent from gastric
cancers.Gastrokine-1 shows strong evolutionary conservation inthe
human, mouse, rat, cow, and pig. Sequence gene analysis (accession
number: BK0017373) showed that the human transcript contains
two potential translation start sites (ATG). The first would generate
a 199 amino acid product lacking the signal peptide, unlike the
second ATG, whichis in-frame,42 bp downstream, and has a more
favourable kozakcontext fortranslation initiation. Comparisonwith
other species revealed homology around the second site only,and its
mature product is predicted at 18 kDa. Micro-sequencing of the
native pig protein by Martin et al. [6] confirmed that the amino
terminal residue was that predicted after signal peptide cleavage.
The second ATG is therefore functional. The theory that
gastrokine-1 is secreted is supported by some reported evidence of
its localisation in cytoplasmic vacuoles. Furthermore, using
immunohistochemistry and Western blot detection, Oein et al. [1]
and Toback et al. [2] showed that gastrokine-1 was present in
mucus at the gastric luminal surface.
Extensive tissue profiling by Northern blotting, in situ
hybridisation and immunohistochemistry, showed that gastro-
kine-1 is highly and specifically expressed in native and metaplastic
gastric epithelium, but such studies are restricted to gastro-
intestinal tissues and a few other tissues such as liver, testis and
placenta [1]. Gastrokine-1 is absent from gastric carcinomas [7] as
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studies with a smaller range and number of samples revealed the
specificity of this protein for gastric type epithelium and the
absence from other normal epithelia. However, two studies using
commercial sources of RNA or cDNA suggested that gastrokine-1
might also occur at low levels in normal placenta, uterus, liver,
kidney, pancreas, and adrenal and salivary glands.
Protein sequence analysis predicted the signal peptide, with
post-translational cleavage, 20 amino acid peptides from the N-
terminus, with a conserved central domain structure named
BRICHOS [8], which was postulated to contain two conservative
cysteine residues that are possibly involved in intra- and/or inter-
disulfide bridges. The putative association of gastrokine-1 with
such a domain structure, and with at least three different possible
functions, has been proposed [8] but has not been conclusively
demonstrated.
To investigate the potential role of gastrokine-1 in smooth
muscle cells, we present the first protocol for purification of native
gastrokine-1 from chicken gizzard. We characterised the bio-
chemical properties of gastrokine-1 with the aim of establishing
some new unexpected biological functions. Using an original
purification procedure, we identified a 20 kDa protein that is
strongly expressed in chicken gizzard smooth muscle. Sequence
blast showed that this protein corresponds to gastrokine-1 and the
protein sequence showed that this protein contains one BRI-
CHOS domain and at least two or possibly three transmembrane
regions. IAEDANS labelling of gastrokine-1 showed that the
protein contains a reactive cysteine residue. The full-length protein
could be shortened into a protease resistant core by eliminating the
first 12 N-terminal residues. Using a newly produced polyclonal
antibody, we observed that gastrokine-1 is well distributed
throughout the gastric epithelium, but also colocalizes with actin
in smooth muscle cells. Moreover, by cross-linking and H-NMR
approaches, we identified the actin binding site on the gastrokine-1
sequence involving the N-terminal acidic region of actin and
demonstrated that the presence of tropomyosin favours gastrokine
dimer formation and its association with actin filaments. Our
results suggest that gastrokine-1 could regulate actin filaments
inside the smooth muscle cytoplasm either to anchor the actin
network to the epithelium cell membrane or to lock actin filaments
for the actin-myosin interaction. Our results highlight a greater
role of gastrokine-1 in cell-cell contact, in the actin network and in
membrane anchorage in smooth muscles.
We also present, for the first time, a purification procedure to
obtain gastrokine-1 as a 90% pure native protein from chicken
gizzard muscle. A series of biochemical and structural studies on
complete purified gastrokine-1 from chicken smooth muscle
gizzard is also reported to investigate the properties of this protein
and its possible relationship with other proteins present in smooth
muscle. We demonstrate that chicken gastrokine-1 is a 20 kDa
protein and contains an actin-binding site involving the N-
terminal acidic region of actin and participates in actin assembly,
as demonstrated by two methods, i.e. crosslinking and H-NMR
techniques. Our results suggest that this gastrokine-1 could also be
considered as a new actin binding protein and could have an
effective locking role on actin filaments either by anchoring the
actin network to the muscle cell membrane or by regulating actin-
myosin interactions in smooth muscle cells.
Materials and Methods
Purification of gastrokine-1
The chicken gizzards used in this study were dissected from
dead euthanized animals obtained from a slaughterhouse in
Re ´moulin (France). In details, fresh chicken gizzard (dissected and
frozen at 280uC) was cut into small fragments (250 g) and mixed
with 1 L of fresh extracting buffer (buffer A: KCl 300 mM, EDTA
1 mM, MgCl2 0.5 mM and imidazole 50 mM, pH 6.9, freshly
supplemented with soybean trypsin inhibitor 5 mg/L, phenyl
methyl sulphate fluoride 5 mm and leupeptin 2 mg/L) in a
Waring blendor 3 times for 5 min. The mixture was heated to
85uC for 4 min and cooled on ice before centrifugation at 4800 g
for 30 min. The supernatant was collected and adjusted to 50%
with ammonium sulphate under mild magnetic agitation. After
centrifugation (4800 g for 30 min) the protein pellet was re-
suspended (final volume about 25–30 ml) in buffer B (Tris HCl
20 mM, pH 7.5, EGTA 1,mM, DTT 0.5 mM). The homogenate
was dialyzed against 1 L of buffer B overnight in cold room under
mild magnetic agitation. After centrifugation (4800 g, 30 min) the
dialyzed homogenate was equilibrated with buffer B and
submitted to Trisacryl DEAE chromatography. The first eluted
fractions were pooled, equilibrated with the buffer B and
submitted to a Trisacryl CM chromatography. After a washing
step with buffer B containing 10 mM NaCl, the retained proteins
were specifically eluted with 100 mM NaCl. All 20 kDa enriched
fractions were pooled and concentrated with Amicon cells using
PM 10 membrane. Finally, the protein mixture was submitted to
chromatography through a Sephacryl S200 column and factions
containing only the 20 kDa protein were pooled and analysed by
SDS-PAGE and Western blot. Protein concentrations were
estimated by the BCA protein assay (Pierce).
Usual preparation, starting from 100 g of chicken gizzard, we
used this method to purify about 10 mg of gastrokine-1 to about
90% purity.
Reactive cysteine labelling of gastrokine-1
The concentration of pure gastrokine-1 and/or its trypsin
proteolytic fragment was estimated using the BCA kit (Pierce). The
thiol content of fresh unmodified gastrokine-1 was measured using
5-59-dithiobis (2-nitrobenzoic acid) in the presence of 4 M
guanidinium chloride. We determined that the total gastrokine-1
protein contained about 2.3 reactive thiol groups, in agreement
with the determined amino acid composition. N-iodoacetyl-N9-(5-
sulfo-1-naphtyl) ethylenediamine (IAEDANS) was incorporated
into gastrokine-1 using 10 molar excess of dye for 30 min in the
dark and with 10 mM Tris HCl, 2 mM MgCl2, pH 7.5. The
reaction was stopped using 10 mM DTE. Excess label was
removed with 60% ammonium sulphate. After centrifugation, the
fluorescent pellet was re-suspended in appropriate buffer and
purified using P10 Sephadex chromatography before use.
Limited proteolysis of gastrokine-1
Native or IAEDANS labelled gastrokine-1 (1 mg/ml) was
treated using 1 mg fresh trypsin stock solution in distilled water
(dilution 1/200=E/S) in 0.5 mM DTE and 10 mM Tris HCl
buffer, pH 7.5. After a time-course treatment of gastrokine-1,
fractions were analysed by SDS-PAGE with Coomassie blue dye
for native protein or by SDS-PAGE under UV light.
Cross-linking
Fresh protein solutions (1 mg/ml=gastrokine-1; mixture of
gastrokine-1/F-actin=1/7, or gastrokine-1/tropomyosin/F-ac-
tin=1/1/7) were dialyzed in 25 mM MES buffer, pH 7.0, and
cross-linking experiments were initiated by adding 10 mM EDC
freshly dissolved in deionised water. The EDC-treated protein
solutions were analyzed in SDS-PAGE 5–18% gradient gel. When
suitable, F-actin was first treated with IAEDANS to incorporate
fluorescent label on cysteine 374 according to previously described
Gastrokine-1 Properties
PLoS ONE | www.plosone.org 2 December 2008 | Volume 3 | Issue 12 | e3854conditions [9]. The gel is first viewed under UV light and then
stained by Coomassie blue dye to compare the gel patterns.
H-NMR
Proton-NMR spectra were recorded at 500 MHz on a Bruker
AMX instrument. The proton resonances of the actin peptide
(5 ml final volume containing 1 ml of each stock solution peptide at
1 mg/ml) were assigned using standard 2-D NMR procedures for
spin system identification (COSY, 1H-1H RELAY and TOCSY)
and sequential consecutive determination (NOESY and ROESY).
Experiments were typically acquired using 2 K points and 512 and
256 blocks (RELAY/TOCSY or NOESY/ROESY, respectively).
The majority of these studies were carried out at pH 6.9 at an
ambient probe temperature of 285 K. Binding titrations involved
the addition of small aliquots of gastrokine-1 stock solution (5 mg/
ml) to reach concentrations corresponding to a 1/20 final molar
ratio. Interactions were routinely detected by using difference
spectroscopy to highlight broadening of the enhanced line upon
the addition of gastrokine-1. The two-pulse spin echo method
(r=60 ms) was also used to better distinguish resonances in the
one-dimensional spectrum.
Antibodies
Polyclonal antibodies directed against gastrokine-1 or caldes-
mon, (using fresh and purified native proteins as antigen), were
produced in the laboratory according to previously described
protocols [10]. Smooth muscle actin was detected using the a-
SMA commercial antibody (Santacruz Biotechnologies). Gastro-
kine-1 and caldesmon polyclonal antibodies were characterized as
specifically detecting the protein bands only with Mr 20 kDa or
120 kDa, respectively.
Immunohistochemistry and immunofluorescence
Timed fertilized white Leghorn eggs (Haas, France) were
incubated at 38uC in a humidified incubator (Coudelou, France)
until testing. Embryos were staged by embryonic day (E). Whole
embryos or dissected gut tissues were fixed in 4% paraformalde-
hyde for 4 (at room temperature) to 18 (at 4uC) h before analysis.
Fixed chick tissues were embedded in paraffin and blocks were cut
into 3 to 5 mm sections and placed on Superfrost Plus slides
(Fisher). Immunohistochemistry were performed using standard
techniques. Briefly, endogenous peroxidase was blocked in 1.5%
hydrogen peroxide for 30–60 min and all controls were obtained
as previously described [11]. Primary antibodies were applied at
the following dilutions: gastrokine-1 polyclonal antibody (1:200);
a-SMA monoclonal antibody actin (1:100) and caldesmon
polyclonal antibody (1:50) and revealed by incubation for 1 h in
ABC reagent according to the manufacturer’s instructions (Dako)
as previously described [11]. Unfixed cryostat sections (3–5 mm) of
various embryonic chicken structures were incubated with specific
primary antibodies for 1 h at room temperature. After washing
with phosphate-buffer saline solution, sections were incubated with
the secondary antibody (Cy3-conjugated goat anti-rabbit IgG, or
with fluorescein-congugated goat anti-mouse antibody, Chemicon
International, 1/4000). All sections were mounted with Mowiol
and observed under a Nikon optiphot-2 microscope.
SDS-PAGE and Western blotting
Purified proteins were generally adjusted to 1–2 mg/ml and a
50 ml aliquot was mixed with 50 ml of SDS buffer containing
0.01% bromophenol blue, 10% glycerol and 5% beta-mercapto-
ethanol. Samples were denatured for 5 min at 95uC. All protein
samples were submitted in duplicate to SDS-PAGE. One resulting
gel was Coomassie blue stained and the other was transferred onto
0.2 mm nitrocellulose membrane. Each blot was blocked in Tris-
buffered saline with 0.1% Tween 20 (TBST) containing 3%
bovine serum albumin (w/v). The corresponding membranes were
incubated with gastrokine-1 primary antibody (1/1000 dilution)
for 1 h at room temperature. After labelling, the membranes were
washed in TBST and then incubated with a phosphatase-labeled
second antibody (Jackson Immuno Research Laboratory, appro-
priate dilution). Antibody-bound proteins were detected with
NBT/BCIP substrate.
Results
Purification and characterisation of gastrokine-1 from
gizzard smooth muscle
Most data related to gastrokine-1 is derived from studies on the
gastric epithelium and more recently from the purification of
gastric epithelial cell populations free of contaminating stromal
elements. This was accurately achieved using laser capture
microdissection, as described in a recent study [12]. In the present
work, we intended to broaden the research field by using whole
chicken gizzard smooth muscle to purify gastrokine-1. We
reviewed the scientific background on biochemical protein
preparation related to smooth muscle and found protocols
addressed to the major expressed proteins contained in this tissue,
such as myosin [13,14], caldesmon [13,14,15], calmodulin [16],
and smooth muscle myosin light chain kinase [17]. In our
experiments, we have initiated purification steps to obtain pure
caldesmon. During the first step of caldesmon purification, we
detected the presence of an abundant protein, with an Mr of
around 20 kDa, in the first eluted fractions during the Trisacryl
DEAE chromatography washing step, whereas these eluted
fractions are generally not used for caldesmon purification [18].
As shown in ‘‘Figure 1’’ (part A), the first eluted fractions were
collected before the salt elution of caldesmon retained on the
Trisacryl column was started. Briefly, the smooth muscle total
protein extract is submitted to heat denaturation and then a crude
protein pellet is obtained after ammonium sulphate precipitation
and centrifugation steps (see Material and Methods section). The
enriched-caldesmon preparation obtained was then submitted to
anionic chromatography. At this step, according to the regular
caldesmon purification protocol, the optical density at 280 nm
must be recorded and return to baseline before performing a salt
gradient to selectively obtain pure caldesmon. After recording the
yellow-stained elution, we analyzed each fraction and pooled them
as presented in ‘‘Figure 1’’ part A, and we obtained an enriched
20 kDa protein solution. Two selective chromatographs were
used, as shown in ‘‘Figure 1’’ part B and C, and we selected the
fractions containing the 20 kDa protein. The Trisacryl CM
column allowed us to purify our 20 kDa protein preparation and,
after concentration with an Amicon cell using PM10 membrane,
the last chromatograph on Sephadex S-200 was analyzed by
PAGE as presented in ‘‘Figure 1’’ part D. A final step of
concentration allows us to obtain a purified 20 kDa protein
preparation.
The total amino acid composition of the purified 20 kDa
protein was recorded and, as summarized in ‘‘Table 1’’, this
protein contained about 175 residues without any His, which is not
frequently observed. Since there were only 2 Met residues and a
few basic residues (4 Lys and 15 Arg), we submitted the 20 kDa
protein to selective CNBR in a first step and to limited trypsin
cleavage in a second step (as shown later in ‘‘Figure 2’’ and
‘‘Supplement S1’’ figure. After HPLC purification in conditions
similar to those described in the ‘‘Table 1’’ legend, the obtained
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determinations. 200 to 300 picomoles of peptide were analyzed
and only sequences with repetitive yields greater than 95% per
cycle were considered as precluding unambiguous determination.
A particularly long peptide was sequenced after CNBR cleavage
up to step 50. The primary sequence of this peptide was:
PALDISIAVLAEQTNNVKGESVLPRSIRVVSRRQRAELRTYGNDI
FALC.
When submitted to protein sequence alignment, this peptide
showed only one significant alignment with gastrokine-1 (GKN1).
Amino acid sequencing of other peptides derived from limited
trypsin cleavages and purified by HPLC were included and
showed a significant alignment with the recently deduced
gastrokine-1 sequence (‘‘Figure 2’’). It is of interest to note that
our CNBR peptide described above was closely neighbouring a
Met residue and corresponded to part of the BRICHOS domain
described in each gastrokine-1 sequence. One conserved cysteine
within the pair was not sequenced, possibly because its
neighbouring region is rich in basic residues, i.e. the target of
trypsin attack. However, the complete sequence of the BRICHOS
domain was obtained in our peptide mapping (12 residues missing
for a total of about 100 residues), with about 35% homology. The
results presented above led us to assume that our purified 20 kDa
protein was clearly the chicken gastrokine-1 protein. This protein
was soluble in buffer containing KCl 300 mM, EDTA 1 mM,
MgCl2 0.5 mM and imidazole 50 mM, pH 6.9, and was found to
be a heat stable protein (85uC for 4 min) that easily refolded. Our
experiment also revealed that gastrokine-1 specifically precipitated
ammonium sulphate by 60% and could be easily re-suspended as
soluble material which led us to investigate some biochemical and
biological properties of gastrokine-1.
Biochemical properties of gastrokine-1
As shown by the amino acid sequence, gastrokine-1 contains
four cysteine residues which could be important for the
BRICHOS domain function [8]. We investigated the cysteine
reactivity versus specific fluorescent labelling using IAEDANS
(‘‘Figure 3’’). In our experimental conditions, the dye was
Figure 1. Purification of the 20 kDa protein contained in a conventional smooth muscle caldesmon preparation. Part A: the elution
pattern under white histogram representation corresponds to Trisacryl DEAE chromatography and the elution pattern is shown and corresponds to the
washing step of this chromatography (with buffer B). The eluted fractions from tubes 10 to 28 were pooled and then submitted to Trisacryl CM
chromatography equilibrated in buffer B. After a washing step with buffer B containing 10 mM NaCl, the retained proteins were specifically eluted as
shown in part B. Part B: the elution pattern shown in the grey histogram representation corresponds to Trisacryl CM treated with 100 mM NaCl and the
20 kDa protein enriched fraction (tube numbers 9 to 17) were pooled and concentrated with Amicon cells using a PM 10 membrane. The resulting
sampleofthis concentratedfractionisshowninthefirst laneofthepart Dgel.PartC:theenriched20 kDapreparationwassubmittedtoSephacrylS-200
chromatography and the elution profile recorded at OD 280 mm indicates, under the black histogram representation, that two proteins were separated
into the corresponding fractions referred to as tubes 9 to 11 and tubes 19 to 25, respectively. Part D: corresponding to the PAGE stained by Coomassie
blue of each eluted fraction, identified as numbered samples of this chromatography, providing access to separate proteins present in the initial
enriched 20 kDa solution according to their respective molecular weights. Some 50 microliters samples of each fraction were denatured for 5 min at
100uC and then analyzed by electrophoresis in 0.1% SDS polyacrylamide slab gels using a 5–18% acrylamide gradient with the Hoefer commercial
apparatus. Therunningbuffer was 25 mMTrisHCl/glycine192 mMin the presenceof 0.1%SDS.TheresultoftheCoomassieblue stainedacrylamidegel
is presented (part D) and showed a clear separation between fractions (HMW) contaminating high molecular weight proteins (tubes 9 to 11) and
enriched 20 kDa protein (tubes 19 to 25). These fractions were pooled and concentrated with a PM 10 Amicon cell.
doi:10.1371/journal.pone.0003854.g001
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fluorescent GNK1 could be prepared and purified without excess
of fluorescent dye, as detailed in the Materials and Methods.
When viewed under UV light, purified GNK1 was detected as a
fluorescent protein band with Mr 20 kDa, as expected, and even
after tryptic cleavage the fluorescent cysteine residue remained
associated with a stable 18 kDa cleaved fragment (‘‘Figure 3’’ top
part). In fact, time-course trypsin attack of native chicken
gastrokine-1 (20 kDa) showed progressive conversion into the
stable 18 kDa fragment (‘‘Figure 3’’ bottom part). This clearly
suggests that gastrokine-1 is a protease resistant protein and that
trypsin treatment cleaves only the 12 N-terminal residues, as
revealed by the amino acid sequencing data already presented in
‘‘Figure 2’’. This is in agreement with the fact that some proteins
containing the BRICHOS domain were cleaved in their N-
terminal part [8]. On the other hand, our findings, in accordance
with sequence analysis results, showed that gastrokine-1 contained
cysteine residues and that one of them could be considered as a
very reactive cysteine easily labelled by IAEDANS. When
screening for the proteolytic product of gastrokine-1, this 18 kDa
fragment was purified and sequenced (‘‘Figure 2’’: bold and italic
sequence). According to the sequence homology, our results
supported previous findings [19], indicating the presence of 3
transmembrane helices spanning residues 18–40, 59–79 and 110–
127, as predicted with TMHMM [20]. However, the expected 14-
amino acid mitogenic domain described previously [2] (‘‘Figure 2’’
residues in italics, 100–113 in human) was only found to be about
30% conserved in the gastrokine-1 chicken sequence. The time
course of tryptic cleavage was not dependent on the fluorescent
modification because native purified gastrokine-1 gave a similar
trypsin induced degradation profile, with a final 18 kDa resistant
protein band (this is completely supported by ‘‘Supplement S1’’
figure, corresponding to the Coomassie blue stained gel for the
time course of the native purified gastrokine-1 preparation).
Gastrokine-1 co-localizes with F-actin
Purified gastrokine-1 was used as antigen and injected in rabbit
to produce a specific polyclonal antibody. This new antibody was
able to detect gastrokine-1 by Western blot, as demonstrated in
‘‘Supplement S2’’ figure. The native form of gastrokine-1 was
detected as a 20 kDa protein band, as shown by the correlation
between the Coomassie blue stained gel pattern of the tryptic
cleavage of gastrokine-1 presented on the left panel of ‘‘Supple-
ment S2’’ figure and the Western blot detection of the same gel
pattern after incubation with polyclonal antibody directed against
purified gastrokine-1. But progressively with conversion of the
20 kDa protein band into the resistant 18 kDa gastrokine-1
cleaved product (as already shown in detail in ‘‘Figure 3’’), there
was only weak detection by this polyclonal antibody for this
cleaved 18 kDa gastrokine-1 product. This led us assume that the
major part of the epitopic determinant of this antibody was
contained within the N-terminal part of gastrokine-1. In the
following experiment, this antibody was used to detect gastrokine-
1 in smooth muscle cross sections by using the immunofluores-
cence labelling technique. ‘‘Figure 4’’ shows the gastrokine-1
distribution during gastrointestinal development in chicken. In
closer detail, gastrokine-1 was (‘‘Figure 4’’, parts a and c) present at
the epithelium level (black arrowheads) in chick gizzard and
duodenum, respectively. Alpha-SMA was not detected in a similar
region, as shown by the serial sections in ‘‘Figure 4’’, parts b and d,
respectively. It is clear that areas corresponding to smooth muscle
were stained with antibodies directed either against gastrokine-1 or
a-SMA (red arrowheads). In addition, gastrokine-1 expression was
observed in isolated islets (green arrow) present in the submucosa
layer, but was not expressed in the enteric nerve cells (black
arrows). Immunofluorescent detection patterns of gastrokine-1
(‘‘Figure 4’’ part e) and a-SMA (‘‘Figure 4’’ parts f) in E8 chick
duodenum were similar in smooth muscle layers, as observed in
the merged image (‘‘Figure 4’’, part g). To confirm these
observations, immunostaining was compared in E16 chick gizzard
and duodenum using antibody directed against either gastrokine-1
or another specific smooth muscle protein, i.e. caldesmon. Here
too (‘‘Figure 4’’, parts h and k), gastrokine-1 was present in the
gastric epithelium and also found to be abundant, rather granular,
cytoplasmic globules (brown), at both the cell apex and bottom
(black arrowheads). Similar areas were not detected as containing
caldesmon. However, as shown with red arrowheads, the smooth
muscle contained gastrokine-1 and caldesmon staining (‘‘Figure 4’’,
parts i and j), and this was also observed in myofibroblasts in the
lamina propria (green arrowhead) and in isolated islets (green
arrow) present in the submucosa layer. Note that gastrokine and
caldesmon were not expressed in enteric nerve cells (black arrows).
Then, and as expected from recent studies on genes induced
during early developmental stages [21], gastrokine-1 was detected
at E8 and E16 stages of the chick gizzard and duodenum.
Table 1. Amino acid composition of the purified 20 kDa
protein.
Amino acid residues Total 20 kDa protein CNBR peptide
ASP 20 2
THR 11 2
SER 7 4
GLU 21 3
PRO ? 2
GLY 13 2
ALA 15 5
CYS 2 1
VAL 18 5
MET 2 0
ILE 11 3
LEU 15 5
TYR 10 2
PHE 6 1
HIS 0 0
LYS 4 1
ARG 14 6
TRP ND ND
GLN ND 2
ASN ND 3
Total 175 48
The pure 20 kDa protein obtained after concentration with an Amicon cell and
using PM10 membrane was then purified by reversed-phase HPLC a using
gradient liquid chromatography and a 4.6675 mm Ultrapore RPSC C8 column.
A linear gradient elution was performed in 60 min at a flow rate of 1 ml/min
using solvent A: 0.08% trifluoroacetic acid in water, and solvent B: 0.08%
trifluoroacetic acid in 60% acetonitrile. Peptide detections were monitored at
220 mm. Such purified 20 kDa preparation was either used as antigen to be
injected in rabbit to obtain specific polyclonal antibody directed against the
20 kDa protein, or for amino acid composition determination. Amino acid
analyses were performed on protein samples hydrolysed at 110uC under
vacuum in 6 M HCl for 24 h using a Beckman Model 332B autoanalyzer. ND: not
determined.
doi:10.1371/journal.pone.0003854.t001
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with previous findings [1,12] but, in addition, there was clear co-
localisation with specific smooth proteins such as smooth actin-
filaments and caldesmon in the gizzard, but also in chick
duodenum. Using fresh sections of gizzard smooth muscle from
adult chicken, labelling with smooth actin or with gastrokine-1
antibodies gave us, as presented in ‘‘Figure 5’’, a similar
distribution of both proteins in the cytoplasmic compartment of
this muscle. A control is included in this figure, indicating that no
fluorescent detection was achieved when each of the primary
antibodies used (i.e. either directed against actin or gastrokine-1)
was omitted from the first incubation step, but when the Cy3-
linked specific fluorescent secondary antibody was still used. This
also gave an indication of the background fluorescence level
obtained after such incubation with only secondary antibody. This
strongly suggests that gastrokine-1 could be a partner of F-actin in
this tissue.
However, to confirm such co-distribution within smooth
muscle, we used gastrokine-1 polyclonal antibody in other tissues
and found, in agreement with recent related data on genes induced
during early development stages [21], that gastrokine was
completely absent in skeletal muscle. However, also in agreement
with this work, we found that gastrokine-1 was weakly present in
bovine heart and, more particularly, targeted to Hiss fibers
(personal data, not shown). Although the presence of gastrokine in
gastric epithelium is quite compatible with the actual focus of its
relationship with only secretory products of mucous epithelia and
its role in cytoprotection, it would certainly be less easy to explain
the gastrokine presence in heart. This will be discussed later in the
conclusion. Then in the following experiments we investigated the
potential interaction between F-actin and gastrokine-1 in solution.
Gastrokine-1 interact with F-actin
Taking advantage of the purified protein solution of the
gastrokine-1 available in our laboratory, we tested the potential
association with F-actin by the cross-linking approach using native
or fluorescent actin (available in the lab). ‘‘Figure 6’’ shows a time-
course analysis carbodiimide-dependent covalent association using
EDC. As expected, the F-actin treated by EDC gave rise to actin
dimer and trimmer (‘‘Figure 6’’ panel A, left part). Gastrokine-1
alone led to the formation of a new protein band around 40 kDa
corresponding to the dimer (‘‘Figure 6’’ panel A, right part).
Interestingly, we observed high accumulation of a new protein
band that was suspected to be the actin-20 kDa product along
with a relative decrease in F-actin dimer formation (‘‘Figure 6’’
panel A, middle part). As shown in ‘‘Figure 6’’ (panel B), covalently
associated proteins composing the protein band (expected to be an
association of actin +20 kDa protein) contained fluorescent
labelled actin (‘‘Figure 6’’ panel B, left part). The same fluorescent
gel was stained with Coomassie blue (‘‘Figure 6’’ panel C, right
part). The left side of the figure shows the result of the 20 min
EDC treatment on the mixture of 20 kDa full length gastrokine-1
and F-actin. The covalent product contained fluorescent actin
migrating at˜Mr of 63 kDa. On the right side of the standard
protein markers, the complete time-course EDC treatment after
Coomassie blue staining of the mixture of stable 18 kDa split
Figure 2. Sequence alignment for various gastrokine-1 proteins. In this representation, we have summarized the gastrokine-1 sequences
already published in a previous work [1] and corresponding to gastrokine-1(GKN1) from pig (line 1), cow (line 2), mouse (line 3), rat (line 4), human
(line 5) and Gallus gallus NCBI (line 6) as compared to our sequence obtained in this work (line 7). The sequence presented in this work was obtained
by sequencing of isolated chicken gizzard GNK1 protein and the first CNBR peptide is underlined in a dashed box. It closely neighboured a
methionine residue and was confirmed by a tryptic overlapping peptide with a sequence corresponding to VVMPALDISAVLAEQT. The N-terminal
tryptic fragment of GNK1 (18 kDa protein) is underlined in a dark box. Note that this peptide mapping allowed us to obtain almost the entire
gastrokine-1 sequence with only 12 residues missing, but after such alignment there was 65–61% homology between our 20 kDa isolated protein
and gastrokine-1 protein from human, pig or mouse, and about 90% homology with the recently published Gallus gallus sequence. The BRICHOS
domain is shown in the large black box.
doi:10.1371/journal.pone.0003854.g002
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contained actin (according to the fluorescent labelling shown on
the left side) and migrated as a protein band at around˜61 kDa.
Then we assumed that all new products initiated by EDC
treatment could correspond to a covalent interaction between F-
actin and native or split gastrokine-1. All of these covalent
associated products were confirmed by Western blot using the
polyclonal gastrokine-1 antibody. This is illustrated in ‘‘Supple-
ment S3’’ figure to ‘‘Figure 6’’. Three selected samples
corresponding to native gastrokine-1 and the actin mixture
submitted to the EDC crosslinking time course presented on the
left part of the Western blot were compared after incubation with
gastrokine-1 antibody and showed (on the right part of the figure)
only protein bands containing gastrokine-1. Native gastrokine-1
was detected as a 20 kDa band, as expected and illustrated in
‘‘Supplement S2’’. However, one major protein band was revealed
with Mr 63 kDa. This new 63 kDa crosslinked protein band was
revealed by specific fluorescence detection in actin and by Western
blot using specific anti-gastrokine-1 antibody. This confirms that it
resulted from the covalent union between actin and gastrokine-1.
Another 40 kDa minor protein band was also present and
assumed to be the gastrokine-1 dimer, as confirmed by Western
blot revelation of the gastrokine-1 crosslink kinetics that will be
presented later in part B of ‘‘Figure 8’’. This could be
preferentially induced by actin but also the result of oxidation of
an older purified GNK1 preparation. In fact, as revealed later, the
fresh GNK1 preparation alone did not induce dimer formation
after EDC treatment.
F-actin residues involved into gastrokine-1 association
To shed further light on the actin residues involved in the
gastrokine-1 association, we used few actin peptides and tested
interactions by the proton NMR technique. Each actin synthetic
peptide was recorded in relation to its amino acid sequence
(‘‘Table 2’’). Proton NMR spectroscopy was performed as detailed
in a previous report [22]. Spectral perturbations resulting from
complex formation between the synthetic actin peptides and
gastrokine-1 were monitored by difference spectroscopy and by
application of the two-pulse spin echo technique [22]. The most
evident association was found between N-terminal peptide
(residues 1 to 28) and gastrokine-1. ‘‘Figure 7’’ shows the
respective records corresponding to the H-NMR spectra of N-
terminal actin peptide alone (A), of the mixture of N-terminal
peptide and gastrokine-1 (B) and the complex formation (C) which
corresponds to the differential spectrum (A–B). Our data showed
that the gastrokine-1/actin interface involves a specific proton
belonging to well identified side chains of a few N-terminal actin
residues. Although the proton mapping could not be precisely
done for each residue, Glu-2 and -4 (E) as well as Thr- 5 and -6 or
Phe-21 were clearly involved in the gastrokine-1 interaction
(shown in bold in the N-terminal sequence of the 28 first actin
amino acid residues). The other protons implicated in the
gastrokine-1 association were in the side chain CH3 of Val/Leu
and Ala or CH2 of Asp residues. According to these results, the
underlined residues, mapped into the following actin sequence :
DEDETTALVCDNGSGLVKAGFAGDDAPR, could corre-
spond to the GNK1 actin binding site. This is in complete
Figure 3. Fluorescent labelling of chicken gastrokine-1 and time course of limited trypsin cleavage. The digestion times are indicated in
the top of the figure and corresponded to the trypsin time course of the purified 20 kDa preparation. Part A: the polyacrylamide slab gel was viewed
under UV light. The 20 kDa fluorescent protein band was progressively converted and accumulated into a still fluorescent 18 kDa protein band. Part
B: the same gel was viewed after Coomassie blue staining. The purified 20 kDa protein band was progressively converted into a stable 18 kDa protein
band and remained stable after 90 min of trypsin attack. Then trypsin cleavage was stopped by adding a 2 molar excess of soybean trypsin inhibitor
(STI) and the stable 18 kDa cleaved protein could be used in other experiments.
doi:10.1371/journal.pone.0003854.g003
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PLoS ONE | www.plosone.org 7 December 2008 | Volume 3 | Issue 12 | e3854Figure 4. Gastrokine-1 expression during gastrointestinal development. Immunostaining for gastrokine-1 in E8 chick gizzard (a–b) and
duodenum (c–d). Gastrokine was present in gastrointestinal epithelia (black arrowheads) and smooth muscle cells (red arrowheads). In addition,
gastrokine was detected in isolated islets present in both smooth muscle (red arrows) and submucosal layers (green arrows). Immunostaining for
alpha-SMA in E8 chick gizzard (b) and duodenum (d). Alpha-SMA was only present in smooth muscle cells (red arrowheads). Immunofluorescence for
gastrokine (e) and alpha-SMA (f) in E8 chick duodenum. Gastrokine and alphha-SMA were present in the smooth muscle layers as shown in the
merged image (g). In addition, gastrokine was present in duodenal epithelial cells (e, g) as observed in (b). Immunostaining for gastrokine in E16 chick
gizzard (h) and duodenum (i). Gastrokine was present in gastrointestinal epithelia (black arrowheads) and smooth muscle cells (red arrowheads).
Gastrokine was widely expressed in smooth muscle layers (h, i), but was not expressed in enteric nerve cells (black arrow), as observed in (i).
Gastrokine expression was also observed in myofibroblasts in the lamina propria (green arrowhead) and in isolated islets (green arrow) present in the
submucosa layer (i). Note that gastrokine was detected in basal epithelial cells in the gizzard (h) and in apical epithelial cells in the duodenum (i).
Immunostaining for caldesmon in E16 chick gizzard (j) and duodenum (k). j, k, Caldesmon was present in gastrointestinal smooth muscle cells (red
arrowheads). Caldesmon was widely expressed in the smooth muscle layers (j, k), but not expressed in enteric nerve cells (black arrow), as observed in
(k). Caldesmon expression was also observed in myofibroblasts in the lamina propria (green arrowhead) and in the muscularis mucosa (red arrow) (k).
Note that Caldesmon was also detected in the most basal epithelial cells (black arrowhead) in the gizzard (j). Scale bars=50 micrometers.
doi:10.1371/journal.pone.0003854.g004
Figure 5. Codistribution of F-actin and gastrokine-1 in adult chicken gizzard smooth muscle Cryostat sections of adult chicken
gizzard were stained using (left part) commercial anti-F-actin and (middle part) anti-gastrokine-1 that we produced as primary
antibodies. Both proteins were similarly detected in the cytoplasm of the gizzard smooth muscle from adult chicken. An example of incubation with
only the secondary fluorescent Cy3-linked fluorescent antibody when omitting either anti-actin or anti-gastrokine-1 primary antibody is shown on the
right. Scale bars=50 micrometers.
doi:10.1371/journal.pone.0003854.g005
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actin and gastrokine-1 which promotes the activation of actin acid
residues for direct crosslink with gastrokine-1, as previously
reported for myosin S1 and/or other actin binding proteins
[23,24,25,26].
Tropomyosin strengthening of gastrokine-1 and actin
interaction
With the aim of determining the potential involvement of
gastrokine-1 in the regulation of the actin network in smooth
muscle cells, we tested the effect of tropomyosin on the gastrokine-
1/actin association. ‘‘Figure 8’’ (panel A) shows the Coomassie
blue gel staining over the time course of EDC treatment of
tropomyosin alone, chicken gastrokine-1 alone, and their mixture
(ratio 1/1). Apart from a strong tropomyosin dimer with an Mr of
about 80 kDa that appeared after 5 min of crosslinking, no other
new protein band was clearly detected. After adding F-actin to this
mixture, we observed that gastrokine-1, actin and tropomyosin
could be associated within a ternary complex. To facilitate the
interpretation of the EDC-induced covalent union, the cross-
Figure 6. Kinetics of EDC cross-linking between F-actin and gastrokine-1 in solution compared to F-actin and gastrokine-1 alone. (A)
Represent the Coomassie blue staining gel pattern of the covalent union induced by EDC treatment of F-actin alone (left part), F-actin and gastrokine-
1 (middle part) and gastrokine-1 alone (right part). When only actin was submitted to EDC crosslinking conditions, actin-dimer and -trimer formation
occurred. When only gastrokine-1 was mixed with EDC, GNK-1 dimer formation occurred, as shown by the label (*), and this entity was still present
when the actin-gastrokine-1 mixture was treated with EDC. (B) A comparison of cross-linking time courses for native gastrokine-1 after 20 min of EDC
treatment and that of trypsin split gastrokine-1 (stable 18 kDa fragment) when mixed with fluorescent F-actin is shown on the left. Note that only
fluorescent bands appeared under UV light and indicated the presence of labelled actin within the fluorescent protein bands detected. Then, as
shown on the right part, the same gel was stained was Coomassie blue and all protein bands were revealed. The 20 kDa protein band corresponding
to gastrokine-1 was aligned with the corresponding molecular weight marker presented in lane St. The 18 kDa protein band corresponding to trypsin
split gastrokine-1 was also viewed and new crosslinked protein bands were clearly identified according to their apparent molecular weights.
doi:10.1371/journal.pone.0003854.g006
Table 2. Synthetic peptide from skeletal actin used to map
the gastrokine-1 interface using H-NMR spectroscopy.
Actin peptide
identification
Actin Residues involved in GNK-1/ actin
interaction
1 to 18 GLU 2 and 4; THR 5 and 6
1 to 28 GLU 2 and 4; THR 5 and 6; PHE 21
16 to 41 PHE 21
29 to 58 Not involved
58 to 84 Not involved
96 to 117 HIS 101
350 to 375 Not involved
All peptides were obtained as previously described [22]. Protons from clearly
identified actin residues are listed as involved in contact between actin and
gastrokine-1 and the most complete H-NMR differential spectrum is provided in
‘‘Figure S7’’. When no differential spectrum was established, the corresponding
peptide is indicated as not involved in actin/gastrokine-1 complex formation.
doi:10.1371/journal.pone.0003854.t002
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blotting analysis using polyclonal anti-gastrokine-1 (‘‘Figure 8’’,
panel B). Three kinetics panels are presented and corresponded to
the tropomyosin and gastrokine-1 mixture (left panel), the ternary
complex obtained by the addition of F-actin (middle panel) and a
control with gastrokine-1 alone. It is interesting to note that in the
absence of actin or tropomyosin, gastrokine-1 was weakly
converted into dimer form ( ˜40 kDa protein band) during EDC
treatment. However, when mixed with tropomyosin or with the F-
actin/tropomyosin mixture, gastrokine-1 dimer formation was
induced before EDC addition. As expected, the presence of F-
actin also led to the new 63 kDa covalently linked product
previously described in our experiments. Moreover, we observed a
new protein band with Mr˜83 kDa. We logically assumed that this
product corresponded to the covalent union between actin and the
gastrokine-1 dimer. In fact, we noted a decrease in gastrokine-1
dimers during the treatment, whereas the 83 kDa product
increased.
Discussion
Many protein functions are currently deduced through
comparative sequence homologies and theoretical prediction on
the basis of cell compartment distributions. Here we described the
gastrokine-1 protein structure and function using conventional
biochemical approaches. The putative cellular function of
gastrokine-1, a component of the protein family containing the
BRICHOS domain, has been proposed [8]. Here we demonstrat-
ed the specific biochemical and cellular properties of chicken
gastrokine-1. It was found that the N-terminal end of this protein
was easily cleaved by proteolytic enzymes such trypsin and
contained an enzyme resistant core of 18 kDa that was easily
labelled by fluorescence directed against a so-called reactive
cysteine residue. Gastrokine-1 was also able to form a dimer. It
was previously described that this protein was expressed in normal
stomach in the superficial/foveolar gastric epithelium [2,3,7]. Our
findings showed that this protein was certainly present but was not
restricted to this area of the stomach but was also present in
smooth muscle cells. Down regulation of this protein in gastric
carcinoma was postulated to be responsible for several diseases
affecting the stomach [1,27], but only the potential role of
gastrokine-1 in mucosal protection was proposed. We provided
evidence of a strong relationship of gastrokine-1 with actin and its
potential role as a new locker and/or membrane anchoring
protein for actin filamentous stress fibers involving the gastrokine-1
structure in the presence of two or possibly three predicted
transmembrane helices.
In fact, cell-cell adhesion could involve the actin network via
cadherin-catenin or integrin complexes within which gastrokine-1
could play a powerful role, and any weakening of these
interactions could lead to a loss of cell-cell contact maintenance.
The recent finding that gastrokine-1 and trefoil factors could have
some interacting capacities is of interest, as recently reported [12].
Trefoil structures probably contribute to their resistance to
protease degradation, but their role in cell-cell contacts is also
evident [28]. Decreased expression of gastrokine-1 and the trefoil
factor may thus favour the development of gastric cancer by
weakening the actin assembly (stress fibers) and disrupting smooth
cell-substratum contacts, or inducing loss of anchoring and thus
anoikis, a form of apoptosis [29]. To determine whether other
pathologies related to smooth muscle but also possibly to cardiac
muscle may occur when gastrokine-1 is down-regulated, it is
necessary to consider how the gastrokine-1/actin complex is
involved in smooth muscle contractile performance–thus giving
Figure 7. Interaction of the N-terminal region of actin with purified chicken GNK-1. Part (A): H-NMR spectrum of actin (200 mM) residues
1–28 containing 250 mM DTT, pH 6.9. Part (B): H-NMR spectrum after gastrokine-1 addition (25 mM) in similar conditions. Part (C): Difference
spectrum (A–B) showing identification of the proton side chain belonging to specific actin residues that were perturbed upon gastrokine-1 addition
and which are indicated in the corresponding area of the 1H-NMR spectrum. The identity of the protons involved, as well as the amino acid to which
they belong, are given in a box over the corresponding peaks. The summary of this particular experiment is stated in the ‘‘Table 2’’ summarizes the
results of this experiment along with other results obtained with different actin peptides.
doi:10.1371/journal.pone.0003854.g007
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GNK1 is absent) association with actin filaments and favoring
modulation of stable actin-myosin complex formation. .Further
research is needed to demonstrate this last point but already
defects in smooth muscle performances must be investigated with
regards to the potential involvement of gastrokine-1 in such related
pathologies and the potential role of gastrokine-1 as a new
potential actin-filament locker should also be considered in the
light of the present data.
Supporting Information
Supplement S1 Time course of limited trypsin cleavage of
native purified gastrokine-1. *The gastrokine-1 protein was
detected as a 20 kDa protein band before tryptic attack and
progressively according to the time scale indicated at the bottom of
the figure. Proteolytic cleavage led to a stable 18 kDa fragment*.
Found at: doi:10.1371/journal.pone.0003854.s001 (6.42 MB TIF)
Supplement S2 Characterisation of the specificity of the anti-
gastrokine-1 polyclonal antibody produced in this study. *The
specificity of the polyclonal antibody obtained after injection of
purified gastrokine-1 into rabbits was first tested against the native
and freshly prepared protein. As expected, the purified sample of
gastrokine-1 was revealed as a single protein band with an Mr of
20 kDa, but in the Western blot pattern of the tryptic cleavage of
gastrokine-1 this antibody seemed to be less able to detect the
18 kDa stable cleaved product. This indicated that the major
epitopic part of this antibody was related to the N-terminal
extremity of gastrokine-1 which may be more accessible and also
more susceptible to proteolytic cleavage.
Found at: doi:10.1371/journal.pone.0003854.s002 (4.66 MB TIF)
Supplement S3 EDC crosslinked kinetics of gastrokine-1 and
actin mixture revealed by Western blot. *Three examples of the
EDC kinetics are presented after Coomassie blue staining on the
left part of the figure. The specific anti-gastrokine-1 antibody that
Figure 8. Importance of the tropomyosin presence during F-actin-gastrokine-1 association. EDC-induced protein stabilisation appeared
as a new protein band as viewed after polyacrylamide gel electrophoresis. In part A, the gel is shown after Coomassie blue staining and at the time
indicated, the kinetics of EDC cross-linked product formation is shown for tropomyosin alone (left panel), gastrokine-1 alone (middle panel) and a
gastrokine-1 and tropomyosin mixture (right panel). Chicken gizzard tropomyosin appeared as a doublet band with a molecular weight of 37 and
40 kDa. No other new band than the 80 kDa product, highlighted with the label (*), was accumulated during the cross-linking experiment containing
tropomyosin. Note that very fresh gastrokine-1 preparations did not accumulate any GNK-1 dimer upon EDC treatment. In part B, the gel was viewed
by the Western blot technique using anti-gastrokine-1 that we produced. Only protein bands containing gastrokine-1 were viewed and, since all
panels contained gastrokine-1, a protein band of 20 kDa appeared. The other protein bands had a molecular weight of around 40 kDa (gastrokine-1
dimer); 63 kDa (corresponding to the actin and gastrokine-1 association) and 83 kDa (covalent association between actin and gastrokine-1 dimers).
The crosslinking conditions are indicated at the top of each panel and, in this panel, are tropomyosin and gastrokine-1 (left panel), ternary complex
between gastrokine-1, actin and tropomyosin (middle panel) and gastrokine-1 alone (right panel).
doi:10.1371/journal.pone.0003854.g008
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products formed after EDC addition. Before the addition of EDC,
only gastrokine-1 was detected as a 20 kDa protein band, as
shown on the right part of the figure and then two protein bands
were progressively revealed with Mr 40 kDa and 63 kDa. These
new protein covalent entities were then identified as the
gastrokine-1 dimer and the covalent union between gastrokine-1
and actin, respectively, and confirmed by the data presented in
‘‘Figure 6’’ using fluorescent actin. However, in others experi-
ments, the formation of a 40 kDa protein bands was found as the
induced tendency for the gastrokine-1 preparation to form GNK1
dimer when mixed with F-actin and/or tropomyosin preparation
respectively, see western blot revealed in ‘‘Figure 8’’, panel B)
Found at: doi:10.1371/journal.pone.0003854.s003 (5.93 MB TIF)
Acknowledgments
We gratefully acknowledge our colleague Dr. Barry A. Levine for
conducting helpful experiments using the H-NMR approach.
Author Contributions
Conceived and designed the experiments: DM. Performed the experi-
ments: KH CN PDSB GH DLC. Analyzed the data: KH CN PDSB FR
DLC DM. Wrote the paper: KH CN PDSB DM.
References
1. Oien KA, McGregor F, Butler S, Ferrier RK, Downie I, et al. (2004) Gastrokine
1 is abundantly and specifically expressed in superficial gastric epithelium, down-
regulated in gastric carcinoma, and shows high evolutionary conservation.
J Pathol 203: 789–797.
2. Toback FG, Walsh-Reitz MM, Musch MW, Chang EB, Del Valle J, et al. (2003)
Peptide fragments of AMP-18, a novel secreted gastric antrum mucosal protein,
are mitogenic and motogenic. Am J Physiol Gastrointest Liver Physiol 285:
G344–353.
3. Walsh-Reitz MM, Huang EF, Musch MW, Chang EB, Martin TE, et al. (2005)
AMP-18 protects barrier function of colonic epithelial cells: role of tight junction
proteins. Am J Physiol Gastrointest Liver Physiol 289: G163–171.
4. Shiozaki K, Nakamori S, Tsujie M, Okami J, Yamamoto H, et al. (2001) Human
stomach-specific gene, CA11, is down-regulated in gastric cancer. Int J Oncol
19: 701–707.
5. Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I (2000) Isolation of two novel
genes, down-regulated in gastric cancer. Jpn J Cancer Res 91: 459–463.
6. Martin TE, Powell CT, Wang Z, Bhattacharyya S, Walsh-Reitz MM, et al.
(2003) A novel mitogenic protein that is highly expressed in cells of the gastric
antrum mucosa. Am J Physiol Gastrointest Liver Physiol 285: G332–343.
7. Yoshihara T, Kadota Y, Yoshimura Y, Tatano Y, Takeuchi N, et al. (2006)
Proteomic alteration in gastic adenocarcinomas from Japanese patients. Mol
Cancer 5: 75.
8. Sanchez-Pulido L, Devos D, Valencia A (2002) BRICHOS: a conserved domain
in proteins associated with dementia, respiratory distress and cancer. Trends
Biochem Sci 27: 329–332.
9. Mornet D, Bertrand R, Pantel P, Audemard E, Kassab R (1981) Structure of the
actin-myosin interface. Nature 292: 301–306.
10. Chazalette D, Hnia K, Rivier F, Hugon G, Mornet D (2005) alpha7B integrin
changes in mdx mouse muscles after L-arginine administration. FEBS Lett 579:
1079–1084.
11. De Santa Barbara P, Williams J, Goldstein AM, Doyle AM, Nielsen C, et al.
(2005) Bone morphogenetic protein signaling pathway plays multiple roles
during gastrointestinal tract development. Dev Dyn 234: 312–322.
12. Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, et al. (2008) Decreased
Expression of Gastrokine 1 and the Trefoil Factor Interacting Protein TFIZ1/
GKN2 in Gastric Cancer: Influence of Tumor Histology and Relationship to
Prognosis. Clin Cancer Res 14: 4161–4167.
13. Ikebe M, Aiba T, Onishi H, Watanabe S (1978) Calcium sensitivity of
contractile proteins from chicken gizzard muscle. J Biochem (Tokyo) 83:
1643–1655.
14. Sobieszek A, Bremel RD (1975) Preparation and properties of vertebrate
smooth-muscle myofibrils and actomyosin. Eur J Biochem 55: 49–60.
15. Bretscher A (1984) Smooth muscle caldesmon. Rapid purification and F-actin
cross-linking properties. J Biol Chem 259: 12873–12880.
16. Sobue K, Kanda K, Adachi J, Kakiuchi S (1983) Calmodulin-binding proteins
that interact with actin filaments in a Ca2+-dependent flip-flop manner: survey
in brain and secretory tissues. Proc Natl Acad Sci U S A 80: 6868–6871.
17. Dalla Libera L, Cavallini P, Fasolo M, Cavanni P, Ratti E, et al. (1990) Smooth
muscle myosin light chain kinase: rapid purification by anion exchange high-
performance liquid chromatography. Biochem Biophys Res Commun 167:
1249–1255.
18. Mornet D, Audemard E, Derancourt J (1988) Identification of a 15 kilodalton
actin binding region on gizzard caldesmon probed by chemical cross-linking.
Biochem Biophys Res Commun 154: 564–571.
19. Tusnady GE, Simon I (2001) The HMMTOP transmembrane topology
prediction server. Bioinformatics 17: 849–850.
20. Punta M, Forrest LR, Bigelow H, Kernytsky A, Liu J, et al. (2007) Membrane
protein prediction methods. Methods 41: 460–474.
21. Halliday DC, Kennedy GC, Hamilton NH, Tarmo S, Alderman J, et al. (2008)
Genes induced during the early developmental stages of the Cane Toad, Bufo
(Chaunus) marinus. Gene Expr Patterns.
22. Levine BA, Moir AJ, Perry SV (1988) The interaction of troponin-I with the N-
terminal region of actin. Eur J Biochem 172: 389–397.
23. Sutoh K (1983) Mapping of actin-binding sites on the heavy chain of myosin
subfragment 1. Biochemistry 22: 1579–1585.
24. Sutoh K (1984) Actin-actin and actin-deoxyribonuclease I contact sites in the
actin sequence. Biochemistry 23: 1942–1946.
25. Sutoh K (1985) [Interactions between actin and actin-binding proteins].
Tanpakushitsu Kakusan Koso 30: 1290–1300.
26. Sutoh K, Hatano S (1986) Actin-fragmin interactions as revealed by chemical
cross-linking. Biochemistry 25: 435–440.
27. Nardone G, Rippa E, Martin G, Rocco A, Siciliano RA, et al. (2007) Gastrokine
1 expression in patients with and without Helicobacter pylori infection. Dig
Liver Dis 39: 122–129.
28. Taupin D, Podolsky DK (2003) Trefoil factors: initiators of mucosal healing. Nat
Rev Mol Cell Biol 4: 721–732.
29. Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13:
555–562.
Gastrokine-1 Properties
PLoS ONE | www.plosone.org 12 December 2008 | Volume 3 | Issue 12 | e3854